Advisory Committee on the Medical Uses of Isotopes; Call for Nominations, 18654-18655 [2015-07993]
Download as PDF
mstockstill on DSK4VPTVN1PROD with NOTICES
18654
Federal Register / Vol. 80, No. 66 / Tuesday, April 7, 2015 / Notices
hearing (even in instances in which the
participant, or its counsel or
representative, already holds an NRCissued digital ID certificate). Based upon
this information, the Secretary will
establish an electronic docket for the
hearing in this proceeding if the
Secretary has not already established an
electronic docket.
Information about applying for a
digital ID certificate is available on
NRC’s public Web site at https://www.
nrc.gov/site-help/e-submittals/applycertificates.html. System requirements
for accessing the E-Submittal server are
detailed in NRC’s ‘‘Guidance for
Electronic Submission,’’ which is
available on the agency’s public Web
site at https://www.nrc.gov/site-help/esubmittals.html. Participants may
attempt to use other software not listed
on the Web site, but should note that the
NRC’s E-Filing system does not support
unlisted software, and the NRC Meta
System Help Desk will not be able to
offer assistance in using unlisted
software.
If a participant is electronically
submitting a document to the NRC in
accordance with the E-Filing rule, the
participant must file the document
using the NRC’s online, web-based
submission form. In order to serve
documents through Electronic
Information Exchange (EIE), users will
be required to install a web browser
plug-in from the NRC Web site. Further
information on the web-based
submission form, including the
installation of the Web browser plug-in,
is available on the NRC’s public Web
site at https://www.nrc.gov/site-help/esubmittals.html.
Once a participant has obtained a
digital ID certificate and a docket has
been created, the participant can then
submit a request for hearing or petition
for leave to intervene through the EIE.
Submissions should be in Portable
Document Format (PDF) in accordance
with NRC guidance available on the
NRC public Web site at https://www.nrc.
gov/site-help/e-submittals.html. A filing
is considered complete at the time the
documents are submitted through the
NRC’s E-Filing system. To be timely, an
electronic filing must be submitted to
the E-Filing system no later than 11:59
p.m. Eastern Time (ET) on the due date.
Upon receipt of a transmission, the EFiling system time-stamps the document
and sends the submitter an email notice
confirming receipt of the document. The
E-Filing system also distributes an email
notice that provides access to the
document to the NRC Office of the
General Counsel and any others who
have advised the Office of the Secretary
that they wish to participate in the
VerDate Sep<11>2014
17:46 Apr 06, 2015
Jkt 235001
proceeding, so that the filer need not
serve the documents on those
participants separately. Therefore, any
others who wish to participate in the
proceeding (or their counsel or
representative) must apply for and
receive a digital ID certificate before a
hearing request/petition to intervene is
filed so that they can obtain access to
the document via the E-Filing system.
A person filing electronically using
the agency’s adjudicatory E-Filing
system may seek assistance by
contacting the NRC Meta System Help
Desk through the ‘‘Contact Us’’ link
located on the NRC Web site at https://
www.nrc.gov/site-help/esubmittals.html, by email at
MSHD.Resource@nrc.gov, or by a tollfree call at (866) 672–7640. The NRC
Meta System Help Desk is available
between 8 a.m. and 8 p.m., ET, Monday
through Friday, excluding government
holidays.
Participants who believe that they
have a good cause for not submitting
documents electronically must file an
exemption request, in accordance with
10 CFR 2.302(g), with their initial paper
filing requesting authorization to
continue to submit documents in paper
format. Such filings must be submitted
by: (1) First class mail addressed to the
Office of the Secretary of the
Commission, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001, Attention: Rulemaking and
Adjudications Staff; or (2) courier,
express mail, or expedited delivery
service to the Office of the Secretary,
Sixteenth Floor, One White Flint North,
11555 Rockville Pike, Rockville,
Maryland, 20852, Attention:
Rulemaking and Adjudications Staff.
Participants filing a document in this
manner are responsible for serving the
document on all other participants.
Filing is considered complete by firstclass mail as of the time of deposit in
the mail, or by courier, express mail, or
expedited delivery service upon
depositing the document with the
provider of the service. A presiding
officer, having granted an exemption
request from using E-Filing, may require
a participant or party to use E-Filing if
the presiding officer subsequently
determines that the reason for granting
the exemption from use of E-Filing no
longer exists.
Documents submitted in adjudicatory
proceedings will appear in NRC’s
electronic hearing docket, which is
available to the public at https://
ehd1.nrc.gov/ehd/, unless excluded
pursuant to an order of the Commission,
or the presiding officer. Participants are
requested not to include personal
privacy information, such as social
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
security numbers, home addresses, or
home phone numbers in their filings,
unless an NRC regulation or other law
requires submission of such
information. With respect to
copyrighted works, except for limited
excerpts that serve the purpose of the
adjudicatory filings and would
constitute a Fair Use application,
participants are requested not to include
copyrighted materials in their
submission.
If a person other than the Licensee
requests a hearing, that person shall set
forth with particularity the manner in
which his interest is adversely affected
by this Order and shall address the
criteria set forth in 10 CFR 2.309(d) and
(f).
If a hearing is requested by the
Licensee or a person whose interest is
adversely affected, the Commission will
issue an Order designating the time and
place of any hearing. If a hearing is held,
the issue to be considered at such
hearing shall be whether this Order
should be sustained. In the absence of
any request for a hearing, or written
approval of an extension of time in
which to request a hearing, the
provisions specified in Section IV above
shall be final 30 days from the date this
Order is issued without further order or
proceedings. If an extension of time for
requesting a hearing has been approved,
the provisions specified in Section IV
shall be final when the extension
expires if a hearing request has not been
received. If payment has not been made
by the time specified above, the matter
may be referred to the Attorney General
for collection. [light face signature
below]
Dated this 27th day of March, 2015.
For the Nuclear Regulatory Commission
Darrell J. Roberts
Acting Regional Administrator Region III
[FR Doc. 2015–07984 Filed 4–6–15; 8:45 am]
BILLING CODE CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes; Call for Nominations
U.S. Nuclear Regulatory
Commission.
ACTION: Call for Nominations.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) is advertising for
nominations for the position of Nuclear
Pharmacist on the Advisory Committee
on the Medical Uses of Isotopes
(ACMUI). Nominees should be a
currently practicing nuclear pharmacist.
SUMMARY:
E:\FR\FM\07APN1.SGM
07APN1
Federal Register / Vol. 80, No. 66 / Tuesday, April 7, 2015 / Notices
Nominations are due on or
before June 8, 2015.
DATES:
Submit an
electronic copy of resume or curriculum
vitae to Ms. Sophie Holiday,
Sophie.Holiday@nrc.gov. Please ensure
that the resume or curriculum vitae
includes the following information, if
applicable: Education; certification;
professional association membership
and committee membership activities;
duties and responsibilities in current
and previous clinical, research, and/or
academic position(s).
FOR FURTHER INFORMATION CONTACT: Ms.
Sophie Holiday, U.S. Nuclear
Regulatory Commission, Office of
Nuclear Material Safety and Safeguards;
telephone (404) 997–4691; email:
Sophie.Holiday@nrc.gov.
SUPPLEMENTARY INFORMATION: The
ACMUI Nuclear Pharmacist provides
advice on issues associated with the
regulation of nuclear pharmacy
applications of byproduct material. This
advice includes providing input on NRC
proposed rules and guidance, providing
recommendations on the training and
experience requirements for Authorized
Nuclear Pharmacists, identifying
medical events associated with these
uses, evaluating non-routine uses of
byproduct material, bringing key issues
in the nuclear pharmacy community to
the attention of NRC staff, as they relate
to radiopharmaceuticals, radiation
safety and NRC medical-use policy.
ACMUI members are selected based
on their educational background,
certification(s), work experience,
involvement and/or leadership in
professional society activities, and other
information obtained in letters or during
the selection process.
ACMUI members possess the medical
and technical skills needed to address
evolving issues. The current
membership is comprised of the
following professionals: (a) Nuclear
medicine physician; (b) nuclear
cardiologist; (c) two radiation
oncologists; (d) diagnostic radiologist;
(e) therapy medical physicist; (f) nuclear
medicine physicist; (g) nuclear
pharmacist; (h) health care
administrator; (i) radiation safety officer;
(j) patients’ rights advocate; (k) Food
and Drug Administration representative;
and (l) Agreement State representative.
NRC is inviting nominations for the
Nuclear Pharmacist to the ACMUI. The
term of the individual currently
occupying this position will end March
29, 2016. Committee members currently
serve a four-year term and may be
considered for reappointment to an
additional term.
mstockstill on DSK4VPTVN1PROD with NOTICES
NOMINATION PROCESS:
VerDate Sep<11>2014
17:46 Apr 06, 2015
Jkt 235001
Nominees must be U.S. citizens and
be able to devote approximately 160
hours per year to Committee business.
Members who are not Federal
employees are compensated for their
service. In addition, members are
reimbursed for travel (including perdiem in lieu of subsistence) and are
reimbursed secretarial and
correspondence expenses. Full-time
Federal employees are reimbursed travel
expenses only.
Security Background Check: The
selected nominee will undergo a
thorough security background check.
Security paperwork may take the
nominee several weeks to complete.
Nominees will also be required to
complete a financial disclosure
statement to avoid conflicts of interest.
Dated at Rockville, Maryland, this 1st day
of April, 2015.
For the U.S. Nuclear Regulatory
Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015–07993 Filed 4–6–15; 8:45 am]
BILLING CODE CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission will convene a
teleconference meeting of the Advisory
Committee on the Medical Uses of
Isotopes (ACMUI) on June 16, 2015, to
discuss the ACMUI Radioactive Seed
Localization subcommittee report and to
hear a presentation from Spectrum
Pharmaceuticals regarding the training
and experience requirements for alpha
and beta emitters. Meeting information,
including a copy of the agenda and
handouts, will be available at https://
www.nrc.gov/reading-rm/doccollections/acmui/meetings/2015.html.
The agenda and handouts may also be
obtained by contacting Ms. Sophie
Holiday using the information below.
DATES: The teleconference meeting will
be held on Tuesday, June 16, 2015, 2:00
p.m. to 5:00 p.m. Eastern Standard
Time.
Public Participation: Any member of
the public who wishes to participate in
the teleconference should contact Ms.
Holiday using the contact information
below.
FOR FURTHER INFORMATION CONTACT: Ms.
Sophie Holiday, U.S. Nuclear
SUMMARY:
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
18655
Regulatory Commission, Office of
Nuclear Material Safety and Safeguards;
telephone: (404) 997–4691, email:
sophie.holiday@nrc.gov.
Conduct of the Meeting
Dr. Bruce Thomadsen, ACMUI
Chairman, will preside over the
meeting. Dr. Thomadsen will conduct
the meeting in a manner that will
facilitate the orderly conduct of
business. The following procedures
apply to public participation in the
meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. Holiday at the
contact information listed above. All
submittals must be received by June 11,
2015, three business days prior to the
meeting, and must pertain to the topic
on the agenda for the meeting.
2. Questions and comments from
members of the public will be permitted
during the meetings, at the discretion of
the Chairman.
3. The draft transcript and meeting
summary will be available on ACMUI’s
Web site https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2015.html on or about July 29, 2015.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in Title 10 of
the Code of Federal Regulations Part 7.
Dated at Rockville, Maryland, this 1st day
of April, 2015.
For the U.S. Nuclear Regulatory
Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015–07990 Filed 4–6–15; 8:45 am]
BILLING CODE CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2015–0058]
Applications and Amendments to
Facility Operating Licenses and
Combined Licenses Involving
Proposed No Significant Hazards
Considerations and Containing
Sensitive Unclassified Non-Safeguards
Information and Order Imposing
Procedures for Access to Sensitive
Unclassified Non-Safeguards
Information
Nuclear Regulatory
Commission.
ACTION: License amendment request;
opportunity to comment, request a
AGENCY:
E:\FR\FM\07APN1.SGM
07APN1
Agencies
[Federal Register Volume 80, Number 66 (Tuesday, April 7, 2015)]
[Notices]
[Pages 18654-18655]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07993]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes; Call for
Nominations
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Call for Nominations.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising
for nominations for the position of Nuclear Pharmacist on the Advisory
Committee on the Medical Uses of Isotopes (ACMUI). Nominees should be a
currently practicing nuclear pharmacist.
[[Page 18655]]
DATES: Nominations are due on or before June 8, 2015.
NOMINATION PROCESS: Submit an electronic copy of resume or curriculum
vitae to Ms. Sophie Holiday, Sophie.Holiday@nrc.gov. Please ensure that
the resume or curriculum vitae includes the following information, if
applicable: Education; certification; professional association
membership and committee membership activities; duties and
responsibilities in current and previous clinical, research, and/or
academic position(s).
FOR FURTHER INFORMATION CONTACT: Ms. Sophie Holiday, U.S. Nuclear
Regulatory Commission, Office of Nuclear Material Safety and
Safeguards; telephone (404) 997-4691; email: Sophie.Holiday@nrc.gov.
SUPPLEMENTARY INFORMATION: The ACMUI Nuclear Pharmacist provides advice
on issues associated with the regulation of nuclear pharmacy
applications of byproduct material. This advice includes providing
input on NRC proposed rules and guidance, providing recommendations on
the training and experience requirements for Authorized Nuclear
Pharmacists, identifying medical events associated with these uses,
evaluating non-routine uses of byproduct material, bringing key issues
in the nuclear pharmacy community to the attention of NRC staff, as
they relate to radiopharmaceuticals, radiation safety and NRC medical-
use policy.
ACMUI members are selected based on their educational background,
certification(s), work experience, involvement and/or leadership in
professional society activities, and other information obtained in
letters or during the selection process.
ACMUI members possess the medical and technical skills needed to
address evolving issues. The current membership is comprised of the
following professionals: (a) Nuclear medicine physician; (b) nuclear
cardiologist; (c) two radiation oncologists; (d) diagnostic
radiologist; (e) therapy medical physicist; (f) nuclear medicine
physicist; (g) nuclear pharmacist; (h) health care administrator; (i)
radiation safety officer; (j) patients' rights advocate; (k) Food and
Drug Administration representative; and (l) Agreement State
representative.
NRC is inviting nominations for the Nuclear Pharmacist to the
ACMUI. The term of the individual currently occupying this position
will end March 29, 2016. Committee members currently serve a four-year
term and may be considered for reappointment to an additional term.
Nominees must be U.S. citizens and be able to devote approximately
160 hours per year to Committee business. Members who are not Federal
employees are compensated for their service. In addition, members are
reimbursed for travel (including per-diem in lieu of subsistence) and
are reimbursed secretarial and correspondence expenses. Full-time
Federal employees are reimbursed travel expenses only.
Security Background Check: The selected nominee will undergo a
thorough security background check. Security paperwork may take the
nominee several weeks to complete. Nominees will also be required to
complete a financial disclosure statement to avoid conflicts of
interest.
Dated at Rockville, Maryland, this 1st day of April, 2015.
For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015-07993 Filed 4-6-15; 8:45 am]
BILLING CODE CODE 7590-01-P